Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NK

NantKwest (NK) Stock Price, News & Analysis

NantKwest logo

About NantKwest Stock (NASDAQ:NK)

Advanced Chart

Key Stats

Today's Range
$2.78
$2.94
50-Day Range
$16.09
$38.70
52-Week Range
$2.52
$45.42
Volume
5.68 million shs
Average Volume
1.57 million shs
Market Capitalization
$317.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantKwest and its competitors with MarketBeat's FREE daily newsletter.

NK Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Space Nk Promo Codes
See More Headlines

NK Stock Analysis - Frequently Asked Questions

NantKwest, Inc. (NASDAQ:NK) released its earnings results on Monday, May, 11th. The biotechnology company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.02. The biotechnology company had revenue of $0.02 million for the quarter. NantKwest had a negative trailing twelve-month return on equity of 56.06% and a negative net margin of 76,658.58%.

NantKwest (NK) raised $150 million in an IPO on Tuesday, July 28th 2015. The company issued 7,000,000 shares at a price of $20.00-$23.00 per share. BofA Merrill Lynch, Citigroup, Jefferies and Piper Jaffray acted as the underwriters for the IPO and MLV & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that NantKwest investors own include Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Dynavax Technologies (DVAX) and OPKO Health (OPK).

Company Calendar

Last Earnings
5/11/2020
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:NK
CIK
1326110
Fax
N/A
Employees
160
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.79 million
Net Margins
-76,658.58%
Pretax Margin
N/A
Return on Equity
-56.06%
Return on Assets
-46.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.74
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
7,927.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.23 per share
Price / Book
2.36

Miscellaneous

Outstanding Shares
109,345,000
Free Float
N/A
Market Cap
$317.10 million
Optionable
Not Optionable
Beta
2.61
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:NK) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners